Description
The design and engineering of new proteins and peptides is revolutionizing biotechnology, with practical applications ranging from novel therapeutic and diagnostic solutions to the optimization of industrial processes and experimental tools. Artificial intelligence and computational approaches have been accelerating the accurate creation of novel functional proteins, bringing fundamental science closer to real-world applications and bridging research centers and industry. These advances are further supported by high-throughput experimental technologies that enable the large-scale generation and evaluation of proteins with greater efficiency.
On October 6 to 8, CNPEM will host the second edition of the Symposium on Protein Design and Engineering. Supported by RosettaCommons, the main international protein design community, led by Nobel laureate Dr. David Baker (University of Washington), and with coorganizers from Fiocruz and industry, the symposium will feature leading international and Brazilian researchers in computational and experimental protein design, who will discuss and present advances in this biotechnological field. The symposium will showcase research and breakthroughs across the entire spectrum, including the development of AI- and computational-based methods, the de novo design of therapeutic binders, self-assembling proteins, biosensors, therapeutic peptides, and vaccines, combining computational and experimental approaches.
A two-day hands-on workshop on AI for Protein Design, held on October 5 and 6 at CNPEM, will mark the symposium pre-event. With international instructors and members of Rosetta, the workshop will focus on training participants in advanced AI approaches and computational methods for protein design with practical applications.